Hisun Pharmaceutical's Veterinary Arm Gets Registration Certificate for Mirtazapine Ointment

MT Newswires Live07-12

Zhejiang Hisun Pharmaceutical's (SHA:600267) unit, Zhejiang Hisun Animal Health Products, received approval from China's Ministry of Agriculture and Rural Affairs to register an ointment for cats for marketing, according to the company's disclosure on the Shanghai Stock Exchange.

The drug, mirtazapine ointment, is suitable for cat weight loss, the Friday disclosure added.

Price (RMB): ¥7.20, Change: ¥+0.01, Percent Change: +0.14%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment